Skip to main content

Table 8 Examples of estimated costs averted by STI program activities

From: Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States

Costs averted

Chlamydia treatment (1,000 people)

Gonorrhea treatment (500 people)

Syphilis treatment (100 people)

HIV C&T (2,000 people)

Direct costs averted

    

STI sequelae costs in treated people

$85,870

$32,440

$57,200

$0

Congenital syphilis costs

$0

$0

$8,890

$0

Population-level STI costs

$71,010

$44,610

$28,600

$0

STI-attributable HIV costs

$34,120

$10,860

$74,010

$0

HIV costs averted through C&T

$0

$0

$0

$97,700

Indirect costs averted

    

Indirect STI costs

$55,980

$31,640

$96,560

$0

Indirect HIV costs

$142,960

$45,490

$310,100

$409,390

Total costs averted

$389,950

$165,030

$575,360

$507,100

  1. HIV C&T: HIV counseling and testing. Indirect HIV costs averted include the costs averted through prevention of STI-attributable HIV cases. Total costs may not match sum of direct and indirect costs due to rounding.